Peripheral Artery Disease (also called peripheral arterial disease) is a common circulatory problem in which narrowed arteries reduce blood flow to the limbs. When a patient develops PAD, then the extremities — usually the legs — do not receive enough blood flow to keep up with demand.
This causes symptoms, most notably leg pain when walking (claudication). Peripheral artery disease is also likely to be a sign of a more widespread accumulation of fatty deposits in the arteries (atherosclerosis). This condition may be reducing blood flow to the heart and brain, as well as the legs.
Patients often can successfully treat peripheral artery disease by quitting tobacco, exercising, and eating a healthy diet. The major cause of peripheral artery disease is atherosclerosis, if the patient has atherosclerosis this means that a plaque has built up inside the artery walls.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market
The Peripheral Artery Disease (PAD) market report also covers emerging drugs, current treatment practices, Peripheral Artery Disease (PAD) market share of the individual therapies, current and forecasted Peripheral Artery Disease (PAD) Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Peripheral Artery Disease (PAD) treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Peripheral Artery Disease (PAD) Market Key Facts
-
Researchers did an American survey of 2,174 patients older than 40 years of age, used the ankle-brachial index (ABI) as a screening tool, and showed a PAD prevalence of 0.9% between the ages of 40 and 49 years, 2.5% between the ages of 50 and 59 years, 4.7% between the ages of 60 and 69 years, and 14.5% for the ages of 70 years and older in a study conducted by Dhaliwal et al. titled “Peripheral arterial disease: epidemiology, natural history, diagnosis, and treatment.
-
According to a study conducted by Alzamora et al. titled “The Peripheral Arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population,” the prevalence of peripheral arterial disease was 7.6% (6.7–8.4), (males 10.2%, females 5.3%). The prevalence of peripheral arterial disease is low, higher in males, and increases with age in both sexes.
Key Benefits of Peripheral Artery Disease (PAD) Market Report
-
Peripheral Artery Disease (PAD) market report provides an in-depth analysis of Peripheral Artery Disease (PAD) Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets, i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
-
The Peripheral Artery Disease (PAD) market report will help in developing business strategies by understanding the Peripheral Artery Disease (PAD) Market trends & developments, key players, and future market competition that will shape and drive the Peripheral Artery Disease (PAD) market in the upcoming years.
-
The Peripheral Artery Disease (PAD) market report covers Peripheral Artery Disease (PAD) current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Peripheral Artery Disease (PAD) market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Peripheral Artery Disease (PAD) Market
The Peripheral Artery Disease (PAD) market size is expected to increase during the forecast period owing to the launch of upcoming therapies.
Increasing awareness, the introduction of novel vaccines and drugs, and changing lifestyles are some other factors driving the growth of the Peripheral Artery Disease market in the 7MM Region.
The Peripheral Artery Disease (PAD) market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Peripheral Artery Disease (PAD) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Peripheral Artery Disease (PAD) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Peripheral Artery Disease (PAD) Epidemiology
The Peripheral Artery Disease (PAD) epidemiology section covers insights about the historical and current Peripheral Artery Disease (PAD) patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Peripheral Artery Disease (PAD) Epidemiology Subtype Segmentation –
-
Prevalent Population of PAD
-
Gender-specific Cases of PAD
-
Diagnosed Cases of PAD
-
Treatable Cases of PAD
Peripheral Artery Disease (PAD) Drugs Uptake and Key Market Players
The Peripheral Artery Disease (PAD) Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Peripheral Artery Disease (PAD) market or expected to get launched in the market during the study period. The analysis covers Peripheral Artery Disease (PAD) market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The dynamics of the Peripheral Artery Disease market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies and incremental healthcare spending across the world.
Peripheral Artery Disease (PAD) Companies:
Helixmith
Daiichi Sankyo
Bayer
Janssen
Rexgenero Limited
Reven Pharmaceuticals
Bristol Meyers Squib
Otsuka America Pharmaceutical
And many others.
Peripheral Artery Disease (PAD) Therapies covered in the report include:
Plavix
Xarelto
Pletal
VM202
REX-001
Edoxaban
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Peripheral Artery Disease (PAD) Competitive Intelligence Analysis
4. Peripheral Artery Disease (PAD) Market Overview at a Glance
5. Peripheral Artery Disease (PAD) Disease Background and Overview
6. Peripheral Artery Disease (PAD) Patient Journey
7. Peripheral Artery Disease (PAD) Epidemiology and Patient Population
8. Peripheral Artery Disease (PAD) Treatment Algorithm, Current Treatment, and Medical Practices
9. Peripheral Artery Disease (PAD) Unmet Needs
10. Key Endpoints of Peripheral Artery Disease (PAD) Treatment
11. Peripheral Artery Disease (PAD) Marketed Products
12. Peripheral Artery Disease (PAD) Emerging Therapies
13. Peripheral Artery Disease (PAD) Seven Major Market Analysis
14. Attribute Analysis
15. Peripheral Artery Disease (PAD) Market Outlook (7 major markets)
16. Peripheral Artery Disease (PAD) Access and Reimbursement Overview
17. KOL Views on the Peripheral Artery Disease (PAD) Market.
18. Peripheral Artery Disease (PAD) Market Drivers
19. Peripheral Artery Disease (PAD) Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/peripheral-artery-disease-pad-market
Latest Reports By DelveInsight
Peripheral Artery Disease (PAD) Epidemiology Forecast
DelveInsight’s Peripheral Artery Disease (PAD) – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Peripheral Artery Disease (PAD) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Bevacizumab Biosimilars Insight
DelveInsight’s, “Bevacizumab Biosimilar Insight, 2020,” report provides comprehensive insights about 40+ companies and 40+ marketed and pipeline drugs in the Bevacizumab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/